Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001733413-18-000001
Filing Date
2018-03-27
Accepted
2018-03-27 14:35:09
Documents
1
Effectiveness Date
2018-03-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10594
  Complete submission text file 0001733413-18-000001.txt   11622
Mailing Address 2801 VIA FORTUNA, SUITE 425 AUSTIN TX 78746
Business Address 2801 VIA FORTUNA, SUITE 425 AUSTIN TX 78746 737-802-1979
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

EIN.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-308663 | Film No.: 18715055